Description
TiraLab Peptide (GLP-2 Analog) for Research Use Only
TiraLab Peptide is a synthetic dual receptor agonist designed for research applications exploring the effects of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activation. This peptide is intended solely for in vitro and preclinical studies to further understand the potential interactions and mechanisms of action related to these pathways.
Research Applications of TiraLab Peptide:
- Receptor Binding Studies: TiraLab Peptide serves as a tool for receptor binding assays in research focused on GIP and GLP-1 receptor interactions.
- Pharmacological Profiling: Investigate the peptide’s effects on signaling pathways and cellular responses to better understand its potential role in metabolic regulation.
- Mechanistic Investigations: Use TiraLab Peptide in studies examining the mechanisms of GIP and GLP-1 receptor activation in laboratory settings.
Key Features of TiraLab Peptide:
- Dual Receptor Agonism: The peptide interacts with both GIP and GLP-1 receptors, providing a unique opportunity to study their combined effects in biological models.
- Laboratory-Grade Quality: TiraLab Peptide is produced for research-grade use and should only be handled in laboratory environments under controlled conditions.
Important Notes:
- This peptide is NOT approved for human or veterinary use.
- It is provided exclusively for research purposes and should only be used in preclinical studies or other scientific investigations.
- No claims regarding clinical efficacy, human health benefits, or therapeutic outcomes are associated with this product.
